Prostate cancer: the contribution of nuclear medicine

This publication has 40 references indexed in Scilit:

• 99Tcm-SM3 immunoscintigraphy to determine whether or not pelvic ultrasound abnormalities are malignant
  Nuclear Medicine Communications, 1999
• THE ACCURACY OF PET SCANNING IN DETECTING PROSTATIC FOSSA RECURRENCE AFTER RADICAL PROSTATECTOMY
  Journal of Urology, 1999
• Site-specific conjugation and labelling of prostate antibody 7E11C5.3 (CYT-351) with technetium-99m
  European Journal of Nuclear Medicine and Molecular Imaging, 1997
• Preliminary Imaging Results Using In-111 Labeled CYT-356 (Prostascintst) in the Detection of Recurrent Prostate Cancer
  Clinical Nuclear Medicine, 1996
• Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer
  Seminars in Nuclear Medicine, 1994
• Radiolabelled monoclonal antibodies in oncology I. Technical aspects
  Nuclear Medicine Communications, 1991
• Ornithine decarboxylase activity in prostate and tumor: a feasibility study for PET with l-[1-14C]- and l-[5-14C]ornithine
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1990
• 2-[18F]fluoroputrescine: Preparation, biodistribution, and mechanism of defluorination
  International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
• Improved Techniques in Radionuclide Imaging of Prostatic Lymph Nodes
  British Journal of Urology, 1979
• Prostatic Lymphoscintigraphy
  British Journal of Urology, 1979